DNA Sequencing For Cancer Research

Through genomic sequencing and analysis, clinicians can identify specific mutations present in a patient’s cancer cells and deliver personalized treatment based on the genetic information. Increased availability and lower costs of next-generation sequencing (NGS) and analysis, along with the on-going identification of an expanding array of cancer-related genetic mutations and biomarkers, are enabling exponential growth in the use of this diagnostic and therapy-targeting tool.
Watch Now

Spotlight

OTHER ON-DEMAND WEBINARS

Cancer Gene Expression Targets Validated Using Novel Histopathology Tools

genengnews

When assessing a potential biological therapeutic candidate, several histopathological technologies are typically employed. This ensures the target expression is validated in both normal and diseased tissues before proceeding with pre-clinical studies. Protein B is a transmembrane glycoprotein that is overexpressed in numerous cancers, including triple-negative breast cancer and is often correlated with the metastatic phenotype. In this GEN webinar, we will discuss the process involved in a typical molecular pathology laboratory. Control cell lines and the RNAScope® Assay were utilized to validate the immunohistochemistry protocol.
Watch Now

AMS - 2021-EMde-Emergency Medicine- Dermatology

americanmedicalseminars.com

EMde-Emergency Medicine- Dermatology: Drug Eruptions: Etiology, Differential Diagnosis and Treatment; Cutaneous Infections and Infestations, Part I: Bacterial, Viral, and Fungal; Cutaneous Infections and Infestations, Part II: Parasites, Bites, and Stings.
Watch Now

Human proteomics: from the operating room to the lab and back

Optimizing platforms for surgical specimen collection and deep human phenotyping was used to enhance protein biomarker identification using proteomic tools.
Watch Now

Why a CT scan and not an MRI? Do I need another cardiac echo? Diagnostic tests for cardiovascular patients

esc365

After watching the webinar, participants will understand: which diagnostic tests are recommended for chronic vs. acute CV patients; and the diagnostic capabilities of noninvasive tests.
Watch Now

Spotlight

resources